A message from the editor of this section, Dr Pablo Avanzas
The purpose of this section is to report the most important current results concerning clinical trials related to cardiovascular pharmacotherapy in various topics such as lipids, hypertension, arrhythmias, heart failure, coronary heart disease, etc. This section will be continuously brought up-to-date with the latest important research in order to provide an ongoing resource.
I hope this tool will contribute to the requirements and necessities of present clinical practice.
Pablo Avanzas, MD, PhD, FESC,
Consultant in Interventional Cardiology, Hospital Universitario Central Asturias
Latest Clinical Trials :